Officially tested the Ebola vaccine on the human body

According to the Washington Post, next week, government researchers in collaboration with British pharmaceutical company - GlaxoSmithKline (GSK) will start testing human Ebola vaccines in the hope of being able to come up with a assessment when people Use this medicine quickly.

Under international pressure, the progress of testing and vaccine production as well as treatment will be accelerated when the number of deaths from Ebola in West Africa reaches 1,500, making Ebola one of the epidemics. The worst disease in history.

Accordingly, the Ebola vaccine will be tested with 60 healthy volunteers in the UK, 40 in Gambia, 40 in Mali and even West Africa under the control of the National Institute of Allergy and Infectious Diseases National Institutes of Health (NIH).

Previously, the vaccine gave promising results when tested on Ebola-infected primates and did not give significant side effects.

Vaccine usually takes 10 years to develop, but GSK hopes they will complete the first phase of the trial by the end of 2014 and start producing 10,000 vaccine doses soon after.

Therefore, if GSK proved its vaccine to be effective, WHO immediately vaccinated people in areas at high risk of disease.

Professor Adrian Hill at Oxford University - a member of the safety testing committee when testing the vaccine, said: "The number of deaths due to Ebola outbreaks has become more serious. In recent years, many types of vaccines similarly produced to vaccinate newborns and adults against a variety of diseases such as malaria, HIV, and hepatitis C, so we believe that this vaccine is also will be able to bring positive signals to the Ebola epidemic ".

According to the latest WHO data, the number of Ebola deaths in West Africa has surpassed 1,500, while the number of cases has exceeded 3,000. As of August 26, the number of Ebola deaths was 1,552 in 3,069 cases of infection in four countries: Sierra Leone, Liberia, Guinea and Nigeria.

WHO has declared a state of emergency for medical epidemics and announced an action plan to fully control and extinguish the disease within 6-9 months.

Director of the Institute of Allergy and Infectious Diseases (NIAID) - Anthony Fauci said: " The best way to prevent Ebola infection is through public health measures: isolation, monitoring, monitoring and "Slowing the spread of disease. Vaccine is also an important tool in the prevention of this disease."